Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.42%
Monthly Change
-11.86%
6 month change
-38.49%
Cambio anual
+6.32%
Cierres anteriores
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volumen
58
Markets
Acciones
Atención Sanitaria
VSTM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
126.38 M
101.54 M
131.7 M
196.26 M
176.85 M
Total liabilities
94.16 M
130.43 M
164.13 M
160.21 M
192.38 M
Total equity
11.06 M
28.89 M
32.43 M
36.06 M
15.53 M
Total liabilities & shareholders' equities
126.38 M
101.54 M
131.7 M
196.26 M
176.85 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Noticias
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley riconferma il rating Buy per le azioni Verastem, mantiene target a $16
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem riporta 17,5 milioni di dollari di ricavi nel Q4 per trattamento oncologico
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Il titolo di Revolution Medicines balza oltre il 20% su possibile acquisizione AbbVie
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Azioni Verastem stabili mentre Mizuho riconferma rating Outperform